FDA’s new voluntary pilot program is designed to help clinicians select appropriate cancer treatments for patients.
Grant Playter
Advertisement
Grant Playter is Associate Editor for Pharmaceutical Technology, BioPharm International, and Pharmaceutical Technology Europe.
Articles by Grant Playter
Advertisement
Latest Updated Articles
FDA Launches Pilot Program Using Cancer Biomarkers to Mitigate RiskPublished: June 21st 2023 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025
3
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
4
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
